299 related articles for article (PubMed ID: 25444903)
1. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment.
Mou W; Xu Y; Ye Y; Chen S; Li X; Gong K; Liu Y; Chen Y; Li X; Tian Y; Xiang R; Li N
Cancer Lett; 2015 Mar; 358(2):115-123. PubMed ID: 25444903
[TBL] [Abstract][Full Text] [Related]
2. Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway.
Tao S; Chen Q; Lin C; Dong H
J Exp Clin Cancer Res; 2020 Sep; 39(1):191. PubMed ID: 32943090
[TBL] [Abstract][Full Text] [Related]
3. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
4. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
6. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
[TBL] [Abstract][Full Text] [Related]
7. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
8. Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors.
Volodko N; Gutor T; Petronchak O; Huley R; Dúcka M; Šmarda J; Borsig L; Beneš P; Knopfová L
Sci Rep; 2019 Aug; 9(1):11634. PubMed ID: 31406165
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages.
Ringleb J; Strack E; Angioni C; Geisslinger G; Steinhilber D; Weigert A; Brüne B
J Immunol; 2018 Jan; 200(2):857-868. PubMed ID: 29229677
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
[TBL] [Abstract][Full Text] [Related]
11. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
12. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer.
Tang X
Cancer Lett; 2013 May; 332(1):3-10. PubMed ID: 23348699
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
15. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
Shash LS; M Kamal KA; Abd Raboh NM
Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
[TBL] [Abstract][Full Text] [Related]
16. Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.
Ding J; Jin W; Chen C; Shao Z; Wu J
PLoS One; 2012; 7(7):e41942. PubMed ID: 22848668
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
[TBL] [Abstract][Full Text] [Related]
18. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.
Chen XW; Yu TJ; Zhang J; Li Y; Chen HL; Yang GF; Yu W; Liu YZ; Liu XX; Duan CF; Tang HL; Qiu M; Wang CL; Zheng H; Yue J; Guo AM; Yang J
Oncogene; 2017 Aug; 36(35):5045-5057. PubMed ID: 28481877
[TBL] [Abstract][Full Text] [Related]
19. Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.
Zhou N; Zhang Y; Zhang X; Lei Z; Hu R; Li H; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Int J Mol Sci; 2015 May; 16(6):11966-82. PubMed ID: 26016502
[TBL] [Abstract][Full Text] [Related]
20. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
